HDAC-IN-29

CAT: 0804-HY-144102Size: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-144102Size:1 Each
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
HDAC-IN-29 (compound 13b) is a potent pan-HDAC inhibitor. HDAC-IN-29 shows antitumor activity[1].
CAS Number
[2695593-95-2]
UNSPSC
12352005
Target
HDAC
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/hdac-in-29.html
Solubility
10 mM in DMSO
Smiles
O=C(NC1=CC=CC=C1)[C@H](CSCCCC(NO)=O)NC(C2=CC=CC=C2)=O
Molecular Formula
C20H23N3O4S
Molecular Weight
401.48
References & Citations
[1]Wang J, et al. Cysteine derivatives as acetyl lysine mimics to inhibit zinc-dependent histone deacetylases for treating cancer. Eur J Med Chem. 2021 Dec 5;225:113799.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-157401HDAC6-IN-29
HY-144292HDAC-IN-30
HY-161688HDAC-IN-73
HY-150597HDAC-IN-46
HY-18362HDAC-IN-5
HY-147966HDAC-IN-43
HY-144293HDAC-IN-31
HY-155182HDAC-IN-62
HY-146750HDAC-IN-37
HY-162910HDAC-IN-79

Alternative Products

CatalogName
T61954-01HDAC-IN-29
MBS3606681-01HDAC-IN-4
T72012-01HDAC-IN-6
T62514-01HDAC-IN-46
T63803-01HDAC-IN-44
T62072-01HDAC-IN-47
T210046-01HDAC-IN-75
T211349-01HDAC-IN-91
T205411-01HDAC-IN-85
T203306-01HDAC-IN-82

Popular Products